Local item extraction
Details for Australian Patent Application No. 2005322850 (hide)
International Classifications
Event Publications
19 July 2007 PCT application entered the National Phase
PCT publication WO2006/074052 Priority application(s): WO2006/074052
11 February 2010 Application Accepted
Published as AU-B-2005322850
25 March 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 26 Feb 2010. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000 2006
15 July 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 26 Feb 2010 2006
22 July 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005322855-Pyrimidine derivatives as kinase modulators and method of use
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser